With 62.53 million shares changed hands, the volume of the stock remained heavier than its average volume of 23.48 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $4.63 whereas the lowest price it dropped to was $3.81. The 52-week range on QSI shows that it touched its highest point at $5.77 and its lowest point at $0.61 during that stretch. It currently has a 1-year price target of $3.25. Beta for the stock currently stands at 2.77.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of QSI was up-trending over the past week, with a rise of 13.89%, but this was up by 230.65% over a month. Three-month performance surged to 365.91% while six-month performance rose 329.00%. The stock gained 118.09% in the past year, while it has gained 51.85% so far this year. A look at the trailing 12-month EPS for QSI yields -0.63 with Next year EPS estimates of -0.79. For the next quarter, that number is -0.18. This implies an EPS growth rate of 6.62% for this year and -24.41% for next year.
Float and Shares Shorts:
At present, 122.78 million QSI shares are outstanding with a float of 97.54 million shares on hand for trading. On 2024-12-13, short shares totaled 11.27 million, which was 790.0 higher than short shares on 1731628800. In addition to Mr. Jeffrey Alan Hawkins as the firm’s President, CEO & Director, Dr. Jonathan M. Rothberg Ph.D. serves as its Founder & Executive Director.
Institutional Ownership:
Through their ownership of 0.35990003 of QSI’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, QSI reported revenue of $787000.0 and operating income of -$28088000.0. The EBITDA in the recently reported quarter was -$29739000.0 and diluted EPS was -$0.18.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With QSI analysts setting a high price target of 5.5 and a low target of 1.0, the average target price over the next 12 months is 3.25. Based on these targets, QSI could surge 34.15% to reach the target high and fall by -75.61% to reach the target low. Reaching the average price target will result in a decline of -20.73% from current levels.
Analysts have provided yearly estimates in a range of -$0.60256 being high and -$0.66744 being low. For QSI, this leads to a yearly average estimate of -$0.635.
